• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有快速心室反应的心房颤动对心房颤动复发的影响:来自CODE-AF注册研究

Impact of Atrial Fibrillation with Rapid Ventricular Response on Atrial Fibrillation Recurrence: From the CODE-AF Registry.

作者信息

Jeong Joo Hee, Baek Yong-Soo, Park Junbeom, Park Hyung Wook, Choi Eue-Keun, Park Jin-Kyu, Kang Ki-Woon, Kim Jun, Lee Young Soo, Kim Jin-Bae, Choi Jong-Il, Joung Boyoung, Shim Jaemin

机构信息

Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul 02841, Republic of Korea.

Department of Internal Medicine, Inha University Hospital, Inha University College of Medicine, Incheon 22332, Republic of Korea.

出版信息

J Clin Med. 2024 Sep 14;13(18):5469. doi: 10.3390/jcm13185469.

DOI:10.3390/jcm13185469
PMID:39336961
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11432096/
Abstract

: Relatively little has been established about the association of rapid ventricular response (RVR) with further recurrence of atrial fibrillation (AF). This study investigated the impact of RVR on the recurrence of AF. : Data were obtained from a multicenter, prospective registry of non-valvular AF patients. RVR was defined as AF with a ventricular rate > 110 bpm. The primary endpoint was the recurrence of AF, defined as the first AF detected on 12-lead electrocardiography during follow-up. Secondary endpoints included manifestation of AF during follow-up and major adverse cardiovascular events (MACEs), a composite of thromboembolic events, major bleeding, myocardial infarction, and death. : Among 5533 patients, 493 (8.9%) presented RVR. Patients with RVR were younger, had smaller left atrial diameters, and more frequently had paroxysmal AF. During the mean follow-up duration of 28.6 months, the RVR group exhibited significantly lower recurrence of AF (hazard ratio: 0.58, 95% confidence interval: 0.53-0.65, < 0.001). There was no significant difference in the occurrence of MACEs between patients with RVR and those without RVR (0.96, 0.70-1.31, = 0.800). AF with RVR was identified as an independent negative predictor of AF recurrence (0.61, 0.53-0.71, < 0.001). : In patients with AF, those with RVR had a significantly lower recurrence of AF without an increase in MACEs. RVR is a favorable marker that may benefit from early rhythm control.

摘要

关于快速心室率反应(RVR)与房颤(AF)进一步复发之间的关联,目前已明确的内容相对较少。本研究调查了RVR对AF复发的影响。

数据来自一项多中心、前瞻性的非瓣膜性AF患者登记研究。RVR定义为心室率>110次/分钟的AF。主要终点是AF复发,定义为随访期间12导联心电图检测到的首次AF。次要终点包括随访期间AF的表现以及主要不良心血管事件(MACE),MACE是血栓栓塞事件、大出血、心肌梗死和死亡的综合指标。

在5533例患者中,493例(8.9%)出现RVR。RVR患者更年轻,左心房直径更小,阵发性AF更为常见。在平均28.6个月的随访期间,RVR组的AF复发率显著较低(风险比:0.58,95%置信区间:0.53 - 0.65,P<0.001)。RVR患者和无RVR患者之间MACE的发生率无显著差异(0.96,0.70 - 1.31,P = 0.800)。伴有RVR的AF被确定为AF复发的独立负性预测因子(0.61,0.53 - 0.71,P<0.001)。

在AF患者中,伴有RVR的患者AF复发率显著较低,且MACE无增加。RVR是一个有利的标志物,可能从早期节律控制中获益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b26/11432096/97145729486c/jcm-13-05469-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b26/11432096/385874c1fdf3/jcm-13-05469-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b26/11432096/c11f205ef680/jcm-13-05469-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b26/11432096/7abec8133c98/jcm-13-05469-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b26/11432096/282530819928/jcm-13-05469-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b26/11432096/97145729486c/jcm-13-05469-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b26/11432096/385874c1fdf3/jcm-13-05469-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b26/11432096/c11f205ef680/jcm-13-05469-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b26/11432096/7abec8133c98/jcm-13-05469-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b26/11432096/282530819928/jcm-13-05469-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1b26/11432096/97145729486c/jcm-13-05469-g005.jpg

相似文献

1
Impact of Atrial Fibrillation with Rapid Ventricular Response on Atrial Fibrillation Recurrence: From the CODE-AF Registry.伴有快速心室反应的心房颤动对心房颤动复发的影响:来自CODE-AF注册研究
J Clin Med. 2024 Sep 14;13(18):5469. doi: 10.3390/jcm13185469.
2
Predicting atrial fibrillation episodes with rapid ventricular rates associated with low levels of activity.预测与低活动水平相关的快速心室率的心房颤动发作。
BMC Med Inform Decis Mak. 2021 Dec 28;21(1):364. doi: 10.1186/s12911-021-01723-3.
3
Multicenter, Phase 2, Randomized Controlled Study of the Efficacy and Safety of Etripamil Nasal Spray for the Acute Reduction of Rapid Ventricular Rate in Patients With Symptomatic Atrial Fibrillation (ReVeRA-201).多中心、2 期、埃替班特鼻喷雾剂治疗有症状的心房颤动患者快速心室率急性降低的疗效和安全性的随机对照研究(ReVeRA-201)。
Circ Arrhythm Electrophysiol. 2023 Dec;16(12):639-650. doi: 10.1161/CIRCEP.123.012567. Epub 2023 Nov 11.
4
Emergency medicine updates: Atrial fibrillation with rapid ventricular response.急诊医学更新:伴有快速心室反应的心房颤动。
Am J Emerg Med. 2023 Dec;74:57-64. doi: 10.1016/j.ajem.2023.09.012. Epub 2023 Sep 18.
5
The impact of atrial fibrillation with rapid ventricular rates and device programming on shocks in 106,513 ICD and CRT-D patients.快速心室率伴心房颤动及装置程控对 106513 例 ICD 和 CRT-D 患者电击的影响。
Heart Rhythm. 2012 Jan;9(1):24-31. doi: 10.1016/j.hrthm.2011.08.005. Epub 2011 Aug 9.
6
[A comparison of CAS risk model and CHADS-VASc risk model in guiding anticoagulation treatment in Chinese patients with non-valvular atrial fibrillation].[中国非瓣膜性心房颤动患者中CAS风险模型与CHADS-VASc风险模型在指导抗凝治疗中的比较]
Zhonghua Xin Xue Guan Bing Za Zhi. 2022 Sep 24;50(9):888-894. doi: 10.3760/cma.j.cn112148-20210826-00740.
7
Myocardial extracellular volume expansion and the risk of recurrent atrial fibrillation after pulmonary vein isolation.心肌细胞外容积扩张与肺静脉隔离术后房颤复发风险
JACC Cardiovasc Imaging. 2014 Jan;7(1):1-11. doi: 10.1016/j.jcmg.2013.08.013. Epub 2013 Nov 27.
8
The difference of burden of ectopic beats in different types of atrial fibrillation and the effect of atrial fibrillation type on stroke risk in a prospective cohort of patients with atrial fibrillation (CODE-AF registry).不同类型心房颤动患者异位搏动负担的差异及心房颤动类型对心房颤动患者前瞻性队列脑卒中风险的影响(CODE-AF 登记研究)。
Sci Rep. 2020 Apr 14;10(1):6319. doi: 10.1038/s41598-020-63370-4.
9
Outcome of catheter ablation for paroxysmal atrial fibrillation in patients with stable coronary artery disease.稳定性冠心病患者阵发性心房颤动导管消融的结果。
Pacing Clin Electrophysiol. 2022 Sep;45(9):1032-1041. doi: 10.1111/pace.14571. Epub 2022 Aug 9.
10
The impact of basic atrial rhythm during catheter ablation of atrial fibrillation on clinical outcomes: Lessons from the German Ablation Registry.导管消融心房颤动时基础心房节律对临床结局的影响:来自德国消融登记处的经验教训。
J Cardiovasc Electrophysiol. 2021 Jul;32(7):1833-1841. doi: 10.1111/jce.15072. Epub 2021 May 18.

本文引用的文献

1
Atrial fibrillation burden: a new outcome predictor and therapeutic target.房颤负担:一个新的预后预测因子和治疗靶点。
Eur Heart J. 2024 Aug 16;45(31):2824-2838. doi: 10.1093/eurheartj/ehae373.
2
Association of typical atrial flutter and cavotricuspid isthmus ablation on clinical recurrence after cryoballoon ablation for atrial fibrillation.典型心房扑动与腔静脉-三尖瓣峡部消融对冷冻球囊消融治疗心房颤动后临床复发的影响
Front Cardiovasc Med. 2023 Dec 15;10:1303635. doi: 10.3389/fcvm.2023.1303635. eCollection 2023.
3
2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
2023 ACC/AHA/ACCP/HRS 指南:心房颤动的诊断与管理——美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2024 Jan 2;149(1):e1-e156. doi: 10.1161/CIR.0000000000001193. Epub 2023 Nov 30.
4
Beta-blockers in atrial fibrillation-trying to make sense of unsettling results.β受体阻滞剂在心房颤动中的应用——试图理解令人不安的结果。
Europace. 2023 Feb 16;25(2):260-262. doi: 10.1093/europace/euad010.
5
Incidence and Determinants of Spontaneous Cardioversion of Early Onset Symptomatic Atrial Fibrillation.早期症状性心房颤动自发转复的发生率及决定因素。
Medicina (Kaunas). 2022 Oct 24;58(11):1513. doi: 10.3390/medicina58111513.
6
Progression of Atrial Fibrillation after Cryoablation or Drug Therapy.冷冻消融或药物治疗后心房颤动的进展。
N Engl J Med. 2023 Jan 12;388(2):105-116. doi: 10.1056/NEJMoa2212540. Epub 2022 Nov 7.
7
Association Between Age and Outcomes of Catheter Ablation Versus Medical Therapy for Atrial Fibrillation: Results From the CABANA Trial.年龄与导管消融与药物治疗房颤结局的相关性:CABANA 试验结果。
Circulation. 2022 Mar 15;145(11):796-804. doi: 10.1161/CIRCULATIONAHA.121.055297. Epub 2021 Dec 22.
8
Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA Trial.心房颤动心力衰竭中消融与药物治疗的比较:CABANA 试验结果。
Circulation. 2021 Apr 6;143(14):1377-1390. doi: 10.1161/CIRCULATIONAHA.120.050991. Epub 2021 Feb 8.
9
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.心房颤动患者的早期节律控制治疗。
N Engl J Med. 2020 Oct 1;383(14):1305-1316. doi: 10.1056/NEJMoa2019422. Epub 2020 Aug 29.
10
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动诊断和管理指南:欧洲心脏病学会(ESC)心房颤动诊断和管理特别工作组,由ESC欧洲心律协会(EHRA)特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.